Although IL-17A and IL-22 secretion can be a hallmark of the adaptive phase response to infection, it is becoming increasingly clear that bacterial pathogens trigger rapid IL-17A- and IL-22-dependent innate defense in the gut mucosa (46). The gene discussed is IL17A; the disease is infection.